Aspira Women's Health Inc. (AWHL) stock
Close on Oct 19, 2026Market cap $9.91MP/E –Yield –
Earnings
Aspira Women's Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Aspira Women's Health's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | Nov 14, 2025before the open | $2.30M | 0.0% | – | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 13, 2025after the close | – | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 19, 2025before the open | $2.28M | +5.9% | -$0.09 | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 27, 2025after the close | $2.30M | +9.5% | -$0.08 | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 14, 2024before the open | $2.30M | – | – | Release |
| Q2 FY2024ended Jun 30, 2024 | Aug 12, 2024after the close | $2.42M | – | -$0.28 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 15, 2024before the open | $2.15M | – | -$0.39 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 28, 2024after the close | $2.10M | – | -$0.30 | Release |
| Q3 FY2023ended Sep 30, 2023 | Nov 13, 2023after the close | – | – | – | Release |
| Q2 FY2023ended Jun 30, 2023 | Aug 14, 2023after the close | – | – | – | Release |
| Q1 FY2023ended Mar 31, 2023 | May 11, 2023after the close | – | – | – | Release |
| Q4 FY2022ended Dec 31, 2022 | Mar 22, 2023after the close | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 10, 2022before the open | – | – | – | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 10, 2022after the close | – | – | – | Release |
| Q1 FY2022ended Mar 31, 2022 | May 11, 2022before the open | – | – | – | Release |
| Q4 FY2021ended Dec 31, 2021 | Mar 23, 2022before the open | – | – | – | Release |
| Q3 FY2021ended Sep 30, 2021 | Nov 10, 2021after the close | – | – | – | Release |
| Q2 FY2021ended Jun 30, 2021 | Aug 12, 2021after the close | – | – | – | Filing |
| Q1 FY2021ended Mar 31, 2021 | May 13, 2021before the open | – | – | – | Filing |
| Q4 FY2020ended Dec 31, 2020 | Mar 25, 2021after the close | – | – | – | Filing |
| Q3 FY2020ended Sep 30, 2020 | Nov 12, 2020after the close | – | – | – | Filing |
| Q2 FY2020ended Jun 30, 2020 | Aug 13, 2020after the close | – | – | – | Filing |
| Q1 FY2020ended Mar 31, 2020 | May 14, 2020after the close | – | – | – | Filing |
| Q4 FY2019ended Dec 31, 2019 | Mar 26, 2020after the close | – | – | – | Filing |
| Q3 FY2019ended Sep 30, 2019 | Nov 12, 2019after the close | – | – | – | Filing |
| Q2 FY2019ended Jun 30, 2019 | Aug 8, 2019after the close | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Aspira Women's Health guided for has been reported
Guidance history
Every forecast Aspira Women's Health put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Nov 14, 2024 | operating cash utilization target | FY2024 | $13.00M – $14.50M | Raised |
| Aug 12, 2024 | operating cash utilization target | FY2024 | $13.00M – $14.50M | Lowered |
| Aug 12, 2024 | operating cash utilization target | FY2024 | $4.80M – $6.30M | Lowered |
| May 15, 2024 | operating cash utilization target | FY2024 | $15.00M – $18.00M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Aspira Women's Health filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Results
- News
- Results
- News
- Results
- News
- Results
- News
- Update
- Results
- Update
- News
- News
- Update
See a number that looks wrong?